Novel antibody blocks Epstein-Barr virus, curing follicular lymphoma — and a plan to reduce cancer in Washington state
SEATTLE – March 4, 2026 – Below are summaries of recent Fred Hutch Cancer Center research findings, patient…
Novartis to build new radioligand therapy site in Denton, Texas, delivering more next‑generation treatments to patients
Facility expected to be operational in 2028 in Dallas-Fort Worth area, expanding largest RLT manufacturing network in USSite…
Novartis to build new radioligand therapy site in Denton, Texas, delivering more next‑generation treatments to patients
Facility expected to be operational in 2028 in Dallas-Fort Worth area, expanding largest RLT manufacturing network in USSite…
Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery
New facility will enable end‑to‑end discovery across key disease areas and technology platforms, joining existing global research sites…
Tip Sheet: How patient advocacy shapes research and care, how HIV/AIDS research benefits other diseases — and invasive lobular breast cancer awareness
SEATTLE — Nov. 4, 2025 — Below are summaries of recent Fred Hutch Cancer Center research findings, patient…
Genetic Testing Enables Tailored Treatments, Better Outcomes
Q: What solutions does OncoAtlas bring to patients and health professionals? A: OncoAtlas is a science-based company that…